Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia

New England Journal of Medicine

Volumn 351, Issue 22, 2004, Pages 2265-2275

  Laughlin, Mary J ^a   Eapen, Mary ^b   Rubinstein, Pablo ^c   Wagner, John E ^d   Zhang, Mei Jei ^c   Champlin, Richard E ^e   Stevens, Cladd ^c   Barker, Juliet N ^d   Gale, Robert P ^f   Lazarus, Hillard M ^a   Marks, David I ^g   Van Rood, Jon J ^h   Scaradavou, Andromachi ^c   Horowitz, Mary M ^b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c NEW YORK BLOOD CENTER   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f Center for Advanced Studies in Leukemia   (United States)

^g UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

^h LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; HLA ANTIGEN; MELPHALAN; METHOTREXATE; TACROLIMUS;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONBIOLOGICAL MODEL; PRIORITY JOURNAL; RECIPIENT; RECURRENCE RISK; TREATMENT FAILURE; UMBILICAL CORD BLOOD; WHOLE BODY RADIATION;

ACUTE DISEASE; ADOLESCENT; ADULT; AGE DISTRIBUTION; BLOOD PLATELETS; BONE MARROW TRANSPLANTATION; CHRONIC DISEASE; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE-FREE SURVIVAL; FEMALE; FETAL BLOOD; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; LEUKEMIA; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; NEUTROPHILS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 9244256765     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa041276     Document Type: Article

References (29)

1. Bone marrow transplants: despite recruitment successes national programs may be underutilized. Washington, D.C.: General Accounting Office, 2002. (GAO publication no. GAO-03-182.)
2. McGlave P, Bartsch G, Anasetti C, et al. Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: initial experience of the National Marrow Donor Program. Blood 1993;81:543-50.
3. Hansen JA, Gooley TA, Martin PJ, et al. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med 1998;338:962-8.
4. Kernan NA, Bartsch G, Ash RC, et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 1993;328:593-602.
5. Szydlo R, Goldman JM, Klein JP, et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol 1997;15:1767-77.
6. Wagner JE, Rosenthal J, Sweetman R, et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood 1996;88:795-802.
7. Kurtzberg J, Laughlin M, Graham ML, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996;335:157-66.
8. Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998;339:1565-77.
9. Gluckman E, Rocha V, Boyer-Chammard A, et al. Outcome of cord blood transplantation from related and unrelated donors. N Engl J Med 1997;337:373-81.
10. Locatelli F, Rocha V, Chastang C, et al. Factors associated with outcome after cord blood transplantation in children with acute leukemia. Blood 1999;93:3662-71.
11. Rocha V, Wagner JE Jr, Sobocinski KA, et al. Graft-versus-host disease in children who have received a cord-blood orbone marrow transplant from an HLA-identical sibling. N Engl J Med 2000;342:1846-54.
12. Rocha V, Cornish J, Sievers EL, et al. Comparison of outcomes of unrelated bone marrow and umbilical cord-blood transplants in children with acute leukemia. Blood 2001;97:2962-71.
13. Barker JN, Davies SM, DeFor T, Ramsay NKC, Weisdorf DJ, Wagner JE. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood 2001;97:2957-61.
14. Saavedra S, Sanz GF, Jarque I, et al. Early infections in adult patients undergoing unrelated donor cord blood transplantation. Bone Marrow Transplant 2002;30:937-43.
15. Hamza NS, Lisgaris M, Yadavalli G, et al. Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated HLA-mismatched allogeneic umbilical cord blood transplantation in adults. Br J Haematol 2004;124:488-98.
16. Ooi J, Iseki T, Takahashi S, et al. A clinical comparison of unrelated cord blood transplantation and unrelated bone marrow transplantation for adult patients with acute leukaemia in complete remission. Br J Haematol 2002;118:140-3.
17. Sanz GF, Saavedra S, Planelles D, et al. Standardized unrelated donor cord blood transplantation in adults with hematologic malignancies. Blood 2001;98:2332-8.
18. Laughlin MJ, Barker J, Bambach B, et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001;344:1815-22.
19. Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995;15:825-8.
20. Flowers ME, Kanasu E, Sullivan KM. Pathophysiology and treatment of graft-versus-host disease. Hematol Oncol Clin North Am 1999;13:1091-112.
21. Klein JP, Moeschberger ML. Survival analysis: techniques of censored and truncated data. New York: Springer-Verlag, 2003.
22. Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972;34:187-220.
23. Andersen PK, Klein JP, Zhang M-J. Testing for centre effects in multi-centre survival studies: a Monte Carlo comparison of fixed and random effects tests. Stat Med 1999;18:1489-500.
24. Clark TG, Altman DG, De Stavola BL. Quantification of the completeness of follow-up. Lancet 2002;359:1309-10.
25. Barker JN, Weisdorf DJ, DeFor TE, Biazar BR, Miller JS, Wagner JE. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood 2003;102:1915-9.
26. Jaroscak J, Goltry K, Smith A, et al. Augmentation of umbilical cord blood (UCB) transplantation with ex vivo expanded UCB cells: results of a phase 1 trial using the AastromReplicell System. Blood 2003;101:5061-7.
27. Fernandez MN, Regidor C, Cabrera R, et al. Unrelated umbilical cord blood transplants in adults: early recovery of neutrophils by supportive co-transplantation of a low number of highly purified peripheral blood CD34+ cells from an HLA-haploidentical donor. Exp Hematol 2003;31:535-44.
28. Shpall EJ, Quinones R, Giller R, et al. Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant 2002;8:368-76.
29. Barker JN, Krepski TP, DeFor TE, Davies SM, Wagner JE, Weisdorf DJ. Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow. Biol Blood Marrow Transplant 2002;8:257-60.